EVEON is proud to be part, again in 2020, of Team Excellence - bpifrance.

EVEON is proud to be in Forbes' ranking as one of the best French inventors, thanks to its strong portfolio of patents, to its development, to R&D investment.

Supported by the European Union, the project ISIS aims to develop and industrialize a connected and secure medical device for automated drug reconstitution.

EVEON is a partner of ROBOLAB project, selected by the 25th call for projects by the FUI inter-ministerial fund. Carried by PMB, a subsidiary of the ALCEN group, CEA’s imaging centre, SHFJ, is also taking part in the project.

EVEON contributes to microfluidic standards development by participating in the design and use of a modular R&D platform using standardized components. Work on this subject has been published in the magazine Sensors and Actuators B: Chemical.

To optimize its fluidic processes, EVEON has collaborated for several years with the laboratory LMGP to understand the causes of the aggregation during the manipulation of proteins. Work on this subject has been published in the magazine Langmuir.

EVEON gave a presentation at 2016 PDA Europe Advanced Therapy Medicinal Products (ATMPs) Conference, on June 7-8, in Berlin (Germany).

EVEON gave a presentation at Bioproduction #5 Cell and Gene Therapies B4B connection, in Evry, 3-4 february 2016